Results 301 to 310 of about 1,334,419 (369)
Reprogramming the melanoma tumor immune microenvironment via combinatorial signal 2/3 gene delivery. [PDF]
Luly KM +11 more
europepmc +1 more source
A Microbiota‐ and IL‐15‐Dependent Innate‐Like B Cell Progenitor Expressing E4BP4
This work identifies CD3.NKp46.CD19.NK1.1. NK‐B cells enriched in PDK1‐deficient yet present in wild‐type bone marrow. IL‐15 (via CD122) and TLR9‐microbiota signaling maintain their E4BP4 expression. These cells demonstrate innate immunity, preferentially differentiate into B cells, and unveil a novel microbiota‐ and IL‐15‐dependent regulatory pathway ...
Junming He +11 more
wiley +1 more source
Unraveling the connection: Inflammatory markers and diabetes mellitus pathogenesis. [PDF]
Obeagu EI.
europepmc +1 more source
Hyaluronic acid‐modified bimetallic peroxide nanocomposites (MgO2‐CuO2@HA) are designed for synergistic tumor therapy. The nanocomposites release Mg2+, H2O2, and Cu2+ in tumor cells, induce cuproptosis via Cu+‐mediated protein aggregation, and activate pyroptosis through caspase‐1/gasdermin D pathways for inducing immunogenic cell death, collectively ...
Guanting He +8 more
wiley +1 more source
Biochemical Markers Involved in Bone Remodelling During Orthodontic Tooth Movement. [PDF]
Fuentes Vera BP +2 more
europepmc +1 more source
Study on proteolysis of glucagon.3-interleukin-2(G.3-IL-2) using enterokinase
Woon Young Lee, Jeewon Lee, In Ho Kim
openalex +1 more source
The Relative Effects of Monotherapies for Psoriatic Nails: A Network Meta-Analysis Study. [PDF]
Gupta AK +3 more
europepmc +1 more source
Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial. [PDF]
Liu T +28 more
europepmc +1 more source

